Entrepreneur-in-residence to work on bridging the gap between foundational research funded by Medicine by Design and the creation of products or ventures that will impact human health.
“Science is about interpreting hard numbers and data, but I’ve realized that science is also an exercise in creative storytelling. I love the visual arts and literature, and I can see the drama in science."
The program’s second year includes new partnerships, enhanced educational opportunities and more research funding.
Scientists at the University of Toronto have discovered a novel way to test self-repair of skeletal muscle, a method with the potential to accelerate treatments for diseases like muscular dystrophy.
Can turning off genetic switches in therapeutic cells help them avoid attack from the immune system?
Researchers have engineered a new method to improve the survival and potency of cell transplants to treat diabetes.
Regen Med in the Clinic, a new partnership between the Ajmera Transplant Centre and Medicine by Design, aims to create linkages between clinicians and scientists & engineers.
Convergence is the key to advancing regenerative medicine and paving the way for novel approaches to treating disease and even preventing it before it starts. This post is just one of many covering the topic of aging as part of Signal’s sixth annual blog carnival.
"We simplify the problems so we can start nibbling at them. With each step, you contribute to the body of knowledge that we can all use to improve people’s health. I like helping to make that impact."
Funding gives cutting-edge regenerative medicine concepts impacting heart disease, lung transplantation, degenerative brain disease and end-stage liver disease a pathway to clinical translation.
Meeting from August 25 to 27 will focus on development and pediatric communities
Computational biology study found two fundamental mechanisms involved in the cell play important roles and may help better control cells used in regenerative medicine applications
$430,000 investment to study if a type of immune cell could be the key to transplanting insulin-producing cells for diabetes treatment
"The infiltration of new technologies into mainstream scientific research is incredible. I mean, synthetic biology, AI, machine learning, resolution at the single cell level. I love interdisciplinary science and I love technology."
Over the past two weeks, PRiME partnered with Medicine by Design to host a virtual Cell and Gene Therapies Innovation Showcase, highlighting novel strategies and enabling technologies poised to advance the field.
